All Stories

  1. Junctions in Jeopardy: the neuromuscular junction is a selective pathological target in Charcot-Marie-Tooth disease
  2. Brain-derived neurotrophic factor coordinates neuron-intrinsic programs to enhance axonal regeneration in human motor neurons
  3. TBK1 activity regulates the directionality of axonal transport of signalling endosomes
  4. Disruption of BDNF signalling in neuropathologies
  5. CNTF specifically slows down the axonal transport of signalling endosomes
  6. TBK1 activity regulates the directionality of axonal transport of signalling endosomes
  7. Processivity and BDNF-dependent modulation of signalling endosome axonal transport are impaired in mice with advanced age
  8. Processivity and BDNF-dependent modulation of signalling endosome axonal transport are impaired in aged mice
  9. Shared mechanisms and pathological phenotypes underlying aminoacyl-tRNA synthetase-related neuropathies
  10. Refining gene delivery to skeletal muscle with a dual-strategy approach of muscle-tropic AAV capsids and muscle-specific promoters
  11. The tyrosine phosphatases LAR and PTPRδ act as receptors of the nidogen-tetanus toxin complex
  12. Age‐specific and compartment‐dependent changes in mitochondrial homeostasis and cytoplasmic viscosity in mouse peripheral neurons
  13. The node of Ranvier influences thein vivoaxonal transport of mitochondria and signalling endosomes
  14. Boosting BDNF in muscle rescues impaired axonal transport in a mouse model of DI-CMTC peripheral neuropathy
  15. Targeting muscle to treat Charcot-Marie-Tooth disease
  16. Brain-derived neurotrophic factor amplifies neuron-intrinsic programs to enhance axonal regeneration in human motor neurons
  17. Age-specific and compartment-dependent changes in mitochondrial homeostasis and cytoplasmic viscosity in mouse peripheral neurons
  18. Spinal Muscular Atrophy: A Rare but Treatable Disease of the Nervous System
  19. Boosting peripheral BDNF rescues impaired in vivo axonal transport in CMT2D mice
  20. Boosting BDNF in muscle rescues impaired axonal transport in a mouse model of DI-CMTC peripheral neuropathy
  21. In vivo imaging of axonal transport in peripheral nerves of rodent forelimbs
  22. Neuroscience highlights in 2022: cytoskeletal transport
  23. Intraperitoneal Injection of Neonatal Mice
  24. Hydrogen peroxide induced by nerve injury promotes axon regeneration via connective tissue growth factor
  25. Editorial: Peripheral nerve anatomy in health and disease
  26. BDNF-dependent modulation of axonal transport is selectively impaired in ALS
  27. Editorial: Pathways and Processes Underpinning Axonal Biology and Pathobiology
  28. Coupling axonal mRNA transport and local translation to organelle maintenance and function
  29. Expanding the Toolkit for <em>In Vivo</em> Imaging of Axonal Transport
  30. A longitudinal and cross‐sectional study of plasma neurofilament light chain concentration in Charcot‐Marie‐Tooth disease
  31. BDNF-dependent modulation of axonal transport is selectively impaired in ALS
  32. Dissection, in vivo imaging and analysis of the mouse epitrochleoanconeus muscle
  33. NMJ-Analyser identifies subtle early changes in mouse models of neuromuscular disease
  34. NMJ-Analyser: high-throughput morphological screening of neuromuscular junctions identifies subtle changes in mouse neuromuscular disease models
  35. Altered Sensory Neuron Development in CMT2D Mice Is Site-Specific and Linked to Increased GlyRS Levels
  36. Intramuscular Delivery of Gene Therapy for Targeting the Nervous System
  37. Developmental demands contribute to early neuromuscular degeneration in CMT2D mice
  38. A video protocol for rapid dissection of mouse dorsal root ganglia from defined spinal levels
  39. A video protocol for rapid dissection of mouse dorsal root ganglia from defined spinal levels
  40. Morphological variability is greater at developing than mature mouse neuromuscular junctions
  41. Developmental demands contribute to early neuromuscular degeneration in CMT2D mice
  42. A video protocol for rapid dissection of mouse dorsal root ganglia from defined spinal levels
  43. Altered sensory neuron development in CMT2D mice is site-specific and linked to increased GlyRS levels
  44. Post-synaptic morphology of mouse neuromuscular junctions is linked to muscle fibre type
  45. Loss of BICD2 in muscle drives motor neuron loss in a developmental form of spinal muscular atrophy
  46. Mice Carrying ALS Mutant TDP-43, but Not Mutant FUS, Display In Vivo Defects in Axonal Transport of Signaling Endosomes
  47. Axonal Transport: The Delivery System Keeping Nerve Cells Alive
  48. In Vivo Imaging of Anterograde and Retrograde Axonal Transport in Rodent Peripheral Nerves
  49. Loss of BICD2 in muscle drives motor neuron loss in a developmental form of spinal muscular atrophy
  50. The evolution of the axonal transport toolkit
  51. Axonal transport and neurological disease
  52. Neuronal over-expression of OXR1 is protective against ALS-associated mutant TDP-43 mislocalisation in motor neurons and neuromuscular defects in vivo
  53. Deacetylation of Miro1 by HDAC6 blocks mitochondrial transport and mediates axon growth inhibition
  54. ALS mice carrying pathological mutant TDP-43, but not mutant FUS, display axonal transport defects in vivo
  55. UBA1/GARS-dependent pathways drive sensory-motor connectivity defects in spinal muscular atrophy
  56. Plexin-Semaphorin Signaling Modifies Neuromuscular Defects in a Drosophila Model of Peripheral Neuropathy
  57. Antisense oligonucleotides and other genetic therapies made simple
  58. Aligned electrospun fibers for neural patterning
  59. Engineered method for directional growth of muscle sheets on electrospun fibers
  60. Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis
  61. Neuropilin 1 sequestration by neuropathogenic mutant glycyl-tRNA synthetase is permissive to vascular homeostasis
  62. Sensory neuron fate is altered in human neuropathy caused by Gars mutations
  63. Methodological advances in imaging intravital axonal transport
  64. Neuropilin 1 sequestration by neuropathogenic mutant glycyl-tRNA synthetase is permissive to vascular development and homeostasis
  65. Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy
  66. Sensory neuron fate is developmentally perturbed by Gars mutations causing human neuropathy
  67. Axonal transport is unnaffected by aging
  68. Synaptic Deficits at Neuromuscular Junctions in Two Mouse Models of Charcot-Marie-Tooth Type 2d
  69. A simple, step-by-step dissection protocol for the rapid isolation of mouse dorsal root ganglia
  70. Vascular Defects and Spinal Cord Hypoxia in Spinal Muscular Atrophy
  71. In vivo imaging of axonal transport in murine motor and sensory neurons
  72. The muscle is a major player in neuropathology of a fly model of peripheral neuropathy
  73. Morphological analysis of neuromuscular junction development and degeneration in rodent lumbrical muscles
  74. Overexpression of survival motor neuron improves neuromuscular function and motor neuron survival in mutant SOD1 mice
  75. Delayed motor neuron-muscle synapse development anticipates degeneration in peripheral neuropathy
  76. Chondrolectin affects cell survival and neuronal outgrowth in in vitro and in vivo models of spinal muscular atrophy
  77. Loss of the E3 ubiquitin ligase LRSAM1 sensitizes peripheral axons to degeneration in a mouse model of Charcot-Marie-Tooth disease
  78. Spinal muscular atrophy at the crossroads of basic science and therapy
  79. Invertebrate models of spinal muscular atrophy: Insights into mechanisms and potential therapeutics
  80. The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy
  81. Conserved Genes Act as Modifiers of Invertebrate SMN Loss of Function Defects
  82. A novel Caenorhabditis elegans allele, smn-1(cb131), mimicking a mild form of spinal muscular atrophy, provides a convenient drug screening platform highlighting new and pre-approved compounds
  83. Functional analysis of nematode nicotinic receptors
  84. C. elegans models of neuromuscular diseases expedite translational research